Search the Newsreel

NMDC Q1 Results Today: Time, Earnings Call, Dividend News, What To Watch, Share Price Performance

Q1 Results: Ashok Leyland, NMDC, Alkem Labs, Bharat Dynamics, Voltas, Physicswallah, others to post earnings on August 14

Does Weaker EPS Guidance And AI Pivot Change The Bull Case For Amdocs (DOX)?

MDXH Looks 79.0% Undervalued on GF Value™ but Faces Value Trap Warning

MDxHealth SA (MDXH) is currently trading at a significant discount to its GF Value, suggesting a 79.0% undervaluation. However, investors are cautioned due to the company's unprofitability, negative cash flow, and a low GF Score™ of 49/100, indicating financial weakness despite strong growth metrics. …

J.P. Morgan Maintains Camden Property Trust(CPT.US) With Hold Rating, Raises Target Price to $114

J.P. Morgan has reiterated its Hold rating on Camden Property Trust (CPT.US) while increasing the target price to $114. This indicates a maintained neutral outlook on the company's stock, despite a raised valuation expectation.

Camden Property Trust stock outperforms competitors on strong trading day

Camden Property Trust (CPT) stock increased by 1.93% to $110.47, outperforming the broader market during a favorable trading session. The S&P 500 Index rose 0.65% and the Dow Jones Industrial Average rose 0.13%. This marks the second consecutive day of gains for Camden Property …

MDxHealth ADR earnings missed, revenue topped estimates

MDxHealth ADR (NASDAQ: MDXH) reported its second-quarter earnings, missing analyst estimates for EPS but exceeding revenue expectations. The company provided a full-year 2026 revenue guidance that falls within the analyst consensus. Despite topping revenue estimates, MDxHealth ADR's stock has seen significant declines over the …

MDU Resources Announces Increased Quarterly Dividend

BISMARCK, N.D., Aug. 13, 2026 /PRNewswire/ -- The board of directors of MDU Resources Group, Inc. (NYSE: MDU) has increased the quarterly dividend on the company's common stock to 14.5 cents per share, for an annualized dividend of 56 cents per share. This represents …

MDB Capital Holdings (MDBH) records $16.1M H1 2026 loss and $33.1M eXoZymes stake

MDxHealth (NASDAQ: MDXH) lifts Q2 2026 revenue 16% but posts deeper loss

Mdxhealth Sells 44M Shares for $20M Gross as Q2 Net Loss Hits $9.5M

MDxHealth (MDXH) sells 44M shares, lifting total stock to 95.4M

MDxHealth SA completed a Registered Direct Offering, issuing over 44 million ordinary shares at $0.454 per share to institutional investors, raising approximately $20.0 million in net proceeds. These funds will be used for working capital, product development, and expanding commercialization activities. Following this offering, …

Earnings call transcript: MDxHealth tops revenue estimates in Q2 2026

MDxHealth reported Q2 2026 revenue of $27.2 million, exceeding Wall Street estimates of $25.89 million, leading to a 33.12% jump in after-hours trading despite a slight EPS miss. The company saw a 16% year-over-year revenue increase and expects full-year 2026 revenue between $110 million …

MDU Resources (MDU) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 2 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Nicole KivistoChief Financial Officer - Jason VollmerTreasurer - Brent Miller TAKEAWAYS Consolidated Net Income -- $21.3 million, reflecting higher retail sales volumes …

MDxHealth SA (MDXH) Reports Q2 Loss, Beats Revenue Estimates

MDxHealth SA (MDXH) reported a Q2 loss of $0.18 per share, missing the Zacks Consensus Estimate of a $0.12 loss. However, the company surpassed revenue estimates with $27.21 million, exceeding the $26.6 million expectation. Despite beating revenue, the stock has significantly underperformed the S&P …

Mdxhealth Reports Second Quarter 2026 Financial Results

Mdxhealth reported a 16% increase in second-quarter 2026 revenue, reaching $27.2 million, driven by strong recovery in its tissue-based business and integration of ExoDx. The company reaffirmed its 2026 revenue guidance of $110-115 million and expects to return to positive adjusted EBITDA by the …

CPT Maintained by JP Morgan -- Price Target Raised to $114

JP Morgan has maintained a "Neutral" rating on Camden Property Trust (CPT), raising its price target to $114. According to GuruFocus, CPT is currently undervalued by 1.9% with a GF Value™ of $112.63 and has a GF Score™ of 77/100. While institutional investors show …

Camden Property Trust (NYSE:CPT) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

JPMorgan Chase & Co. has raised its price target for Camden Property Trust (CPT) from $113 to $114, maintaining a "neutral" rating and suggesting a 3.3% upside. Other analysts have also adjusted their ratings and price targets for CPT, with the stock currently holding …

Amdocs (DOX) Q3 2026 Earnings Call Transcript

Kamdhenu Ventures: पहिल्या तिमाहीत मोठा तोटा, कंपनीत मोठे बदल!

BofA Adjusts Price Target on Camden Property Trust to $132 From $134

BofA (Bank of America) has adjusted its price target for Camden Property Trust (CPT) to $

MDB Capital Holdings Provides Second Quarter 2026 Update

MDB Capital Holdings, LLC (NASDAQ: MDBH) provided an update for the quarter ended June 30, 2026, highlighting successful IPOs for Buda Juice and Ticketplus, and the underwriting of eXoZymes. The company also reported a net loss of approximately $16.1 million for the first six …

Is Wall Street Bullish or Bearish on Camden Property Stock?

Camden Property Trust company logo displayed on mobile phone By Pitler Valued at $10.9 billion by market cap, Camden Property Trust (CPT) is a Houston-based multifamily real estate investment trust (REIT) focused on owning, managing, developing, redeveloping, acquiring, and repositioning apartment communities across the …

Pediatrix Medical Group, Inc. Stock 12‑Month Price Target Cut to $26, Implies 2% Downside

The average 12-month price target for Pediatrix Medical Group, Inc. (MD) stock has been lowered from $26.17 to $26 by 5 analysts, with a range of $21 to $28 per share. This new target suggests a potential 2% downside from the August 12 closing …

Amdocs at Oppenheimer conference: ai push targets telecom reinvention

Amdocs (DOX) unveiled a new strategy at the Oppenheimer 29th Annual Technology, Internet & Communications Conference, focusing on AI, cloud acceleration, edge computing, and telecom connectivity. The company aims to reinvent the telecom industry by leveraging AI for operational efficiency and creating new revenue …

AMD Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Barrow Hanley Global Investors (MDU) discloses 6.3% ownership in MDU Resources

Barrow Hanley Global Investors, a Delaware LLC, has disclosed a 6.3% ownership stake in MDU Resources Group Inc. This ownership, totaling 13,056,724 common shares, was reported in a Schedule 13G SEC filing. The firm holds sole voting power over 9,156,673 shares and shared voting …

MDB Capital Holdings LLC Class A common (MDBH) Live Share Price, Invest From India

TherapeuticsMD: Q2 Earnings Snapshot

This article provides a Q2 earnings snapshot for TherapeuticsMD. However, the content of the article is empty, indicating that specific financial details were not included or were unavailable at the time of extraction.

MDU Resources Group Inc (MDU) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of MDU Resources Group Inc (MDU), highlighting its current price momentum score, support and resistance levels, and indicator readings. It details various technical indicators like MACD, RSI, and Moving Averages, offering a neutral signal for the stock based …

Wasatch Advisors LP Boosts Stake in Pediatrix Medical Group, Inc. $MD

Wasatch Advisors LP increased its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 21.9% in the second quarter, holding 2.50 million shares valued at approximately $63.3 million. Institutional investors now own 97.71% of the company's stock, which recently reported strong quarterly earnings, beating revenue …

Morgan Stanley Adjusts PT on Camden Property Trust to $118 From $120, Keeps Equalweight Rating

Morgan Stanley has revised its price target for Camden Property Trust (CPT) to $118, down from $120, while maintaining an "Equalweight" rating on the stock. This adjustment reflects a moderated outlook for the residential REIT. Other recent analyst actions include BNP Paribas adjusting its …

Amdocs is one of the 5% of companies turning AI into real P&L returns. Here's how.

Amdocs, a telecoms services giant, has successfully leveraged AI to achieve significant P&L returns, standing out from the 95% of companies that see no gain from AI investments. By focusing on skill-based organization and internal mobility, Amdocs increased internal mobility to 40% and reduced …

TherapeuticsMD Q2 2026 License Revenue Drops 8.7% Year Over Year

TherapeuticsMD's Q2 2026 license revenue, primarily from the Mayne License Agreement, dropped 8.7% year over year to $864 thousand, leading to a 70% decline in net income from continuing operations. The company has fully exited research, development, and commercial operations, relying solely on this …

TherapeuticsMD Q2 2026 Earnings: License Revenue and Net Income Decline

TherapeuticsMD reported a decline in Q2 2026 license revenue and a significant drop in net income, while operating expenses slightly increased. The company continues to rely heavily on licensee performance and milestone payments, with an IMVEXXY milestone expected in Q3 2026. TherapeuticsMD is also …

LifeMD, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:LFMD) 2026-08-11

LifeMD, Inc. published its Q2 2026 earnings call presentation, reporting an EPS of -$0.15, missing estimates by $0.10, and revenue of $47.28M, down 24.01% year-over-year and missing estimates by $1.82M. The presentation is provided for investors to review the company's financial performance.